Masimo Corp (NASDAQ:MASI)

I think the selling is overdone here. I am worried that MASI is a one-trick pony, but I am encouraged by their efforts to exclude knockoffs from cutting off their sales of consumables. When your much larger competitor has to license your IP, you are doing well.

numerous studies coming out saying their technology is not as advertised.
Most of their profit from law suits not sales, royalties

I interviewed at this company 2 years ago (didn't get the job :( ....) but having reasearched the business and seeing its future potential I really took a shine to it. As MASI is hitting a 52 wk low, I'm adding (doubling) my position in the company today. Although they missed the street's expectations (short term perspective) I am looking at the long term prospects for their growth and future opportunities overall and I think MASI is a long-term winner.

Here's the buy rec:
http://www.fool.com/investing/general/2011/09/12/this-may-be-the-next-great-growth-opportunity.aspx

Rising Star Buy:

http://www.fool.com/investing/general/2011/09/12/this-may-be-the-next-great-growth-opportunity.aspx

Covestor Model Manager Alphamark Advisors Bought MASI in his Small Cap Growth Covestor Model ( http://covestor.com/Alphamark-Advisors )

Matt Dolan, analyst, Roth Capital Partners says, "Cost-effectiveness is a good justification (for a hospital to buy this gear). The unquantifiable benefit comes from reducing patient risk." Masimo's noninvasive pulse oximetry systems are used in hospitals, out-patient surgery centers, by emergency services and will soon show up in physicians' offices.

My sister is type 1 Diabetic,so I know a bit about blood monitors. The Medical Industry has been hit hard by the economic downturn and increasing costs for patients. Companies such as Masimo will bounce back quickly in a recovery due to a high cost to benefit ratio of their products.

non-invasive hgb monitoring is going to be hot

got FDA approval for a hemoglobin monitoring technology

Up on 6x normal volume

Guys and gals, this is the kind of tip you're looking for:
My mother is the EMS coordinator for the Bay Area/Northern California fire and medical departments, and she is doing a revolutionary study on the long term effects of Carbon Monoxide on firefighter's respitory systems.
She has concluded, over a period of five plus years of intense research, that firefighters (especially forestry divisions) do not adequately protect against Carbon Monoxide, and the effects on the body are much worse than those from cigarettes.
Here's where MASIMO comes into play. . . She is working concurrently with Masimo, developing an on-site Carbon Monoxide monitoring device, to be used on firefighters on the scene of fires. If they show dangerous levels, they are to be put on Oxygen, which reverses the adverse effects of carbon monoxide.
She is working on a statewide/national bill that would REQUIRE ALL FIRE STATIONS TO USE THIS PRODUCT. Every single fire station in America will be using Masimo non invasive monitoring devices, thanks to my mother's hard work. . . you can thank us later :)

Massimo blood gas analyzers do something that the competition does not - it works with existing equipment AND it can function by itself as a new purchase. The strides that Masi has made in monitoring CO in the blood for Emergency Techs to use in the field has an incredible edge in initiating appropriate care in a timely manner.

Right area, right time. With Boomers begining to retire this sector will outperform for the next several years...and this stock in particular is positioned for growth which will out pace the sector.

Masimo is the only manufacturer of a monitor that reads carboxi hemoglobin. That determines the levels of CO in your blood. That allows emergency medical providers to determine if you have CO poisoning without doing an arterial blood gas in the hospital. Speeding up treatment

They seem to have a very innovative solution in in measuring CO2 levels in the blood. I see in the news that some hospitals are already switching to their products. If it turns out to be a big hit and becomes a must have for every hospital then the stock will shoot up.

As the largest demographic group in our country's history (baby boomers) grows older each day and begins to succumb to the ills of their fast food and high stress lifestyles, medical devices that improve patient care, are truly innovative, and developed by well run companies will do well. Very Well! The older we get, the more we fear death, the more we complain, the more we vote and demand Washington do something about our plight i.e. health care in the next 5-20 years.

Its stock price continues to increase due to its gain in market share and prospects for the future. Also, there are talks about emerging technology that they have patented and are developing which can come to fruition within the next few years.

they make a great product, that every hospital will use over and over again.

Revenue and earnings are projected to rise 25% this fiscal year. The company has always been on the rise since it's inception.